tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Maneka Mirchandaney, 6 are a BUY (66.67%), 3 are a HOLD (33.33%).
Analyst Maneka Mirchandaney, carries an average stock price target met ratio of 63.33% that have a potential upside of 39.04% achieved within 411 days. Previously, Maneka Mirchandaney worked at EVERCORE.
Maneka Mirchandaney’s has documented 20 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CRNX, Crinetics Pharmaceuticals at 11-Sep-2023.
Analyst best performing recommendations are on SGEN (SEAGEN).
The best stock recommendation documented was for SGEN (SEAGEN) at 5/17/2021. The price target of $153 was fulfilled within 3 days with a profit of $5.02 (3.39%) receiving and performance score of 11.31.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 02-Sep-2026
27 days ago
(02-Sep-2026)
5/8 (62.5%)
$47.5 (111.76%)
407
Buy Since 02-Jul-2026
$85
$0.05 (0.06%)
$55
2 months 1 days ago
(28-Jul-2026)
1/3 (33.33%)
$1.14 (1.36%)
5
Buy Since 15-May-2026
$85
$0.05 (0.06%)
$88.14
2 months 21 days ago
(08-Jul-2026)
0/3 (0%)
$1.51 (1.81%)
Buy Since 13-Aug-2018
2 months 21 days ago
(08-Jul-2026)
4/4 (100%)
$26.41 (194.33%)
1507
Buy Since 07-Jul-2026
$85
$0.05 (0.06%)
$55
2 months 22 days ago
(07-Jul-2026)
3/4 (75%)
$1.47 (1.76%)
352
